A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children

Autor: Nasser, Azmi 1, ∗, Liranso, Tesfaye 1, Adewole, Toyin 1, Fry, Nicholas 1, Hull, Joseph T. 1, Chowdhry, Fatima 1, Busse, Gregory D. 1, Cutler, Andrew J. 2, Jones, Nandita Joshi 3, Findling, Robert L. 4, Schwabe, Stefan 1
Zdroj: In Clinical Therapeutics August 2020 42(8):1452-1466
Databáze: ScienceDirect
Externí odkaz: